chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache, Myalgia, Fever, Diarrhea & NauseaVomiting Narrative:  Employee presented to ER for fever of 102.3, myalgia, diarrhea and headache; rec'd COVID test (-), fluids, Tylenol and Zofran. S/S resolved within 24 hours of vaccine.
soreness in his left arm; tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness in his left arm) and FATIGUE (tired) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A, 044B21A and 032F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PAIN (soreness in his left arm) and FATIGUE (tired). At the time of the report, VACCINATION SITE PAIN (soreness in his left arm) and FATIGUE (tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment  medications were reported. The patient experienced no side effects or adverse reactions to the second shot. No Adverse reactions or side effects were reported after the booster dose.   This case was linked to MOD-2022-560498.
I awoke at 3:15 am, with my face swollen, including eyes, cheeks, below jaw line and lips.; Minor headache; slight nausea; This is a spontaneous report received from a contactable consumer. A 70-year old-female patient received first dose of bnt162B2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number: EM9809) via an unspecified route of administration on left arm on 22Feb2021 at 21:00 as single dose for covid-19 immunization. Concomitant medications included: Calamine lotion, benefiber, calcium600/vitamin D. Medical history included allergies to Penicillin, statins, metals. The patient underwent lab tests and procedures, which included elbow replacement on an unspecified date in 2016. It was reported that 18 hours after injection, on 23Feb2021 at 3:15 am, patient woke up with face swollen, including eyes, cheeks, below jaw line and lips. There was no indication of swollen tongue, no difficulty breathing or swallowing. Minor headache and slight nausea. The adverse events required emergency room visit. Prior to the vaccination, the patient was not diagnosed with COVID-19. No covid test post vaccination. No other vaccine in four weeks. The patient didn't receive other medication in two weeks. Therapeutic measures were taken as a result of events and included treatment with: Benadryl, Famotidine. Outcome of the events was recovering
7JAN97 started crying approx 11Pm;cried all noc >3hr-abnormal cry;fever 101 lasted 2 days;fever 104;pt hosp;t104 x 3 days;
Right arm swole up from shoulder to wrist. Enlarged, discolored. Shoulder Pain. Discomfort. Tingling.
large warm area w/itching on rt arm @ inject site-onset 3 days p/inject; aching, t99.2 since noc of inject;
about 7 hours after injection of sedond Moderna Covid-19 vaccine, the left arm became very sore and by the next morning was noticeable red and slightly swollen; very tender to the touch (skin hurt); this symptom lasted for about 4 days.  A low fever 99F was observed in midafternoon for 3 or 4 days but subsided by suppertime.  Chills seemed to occur in midevening and into bedtime, requiring hot drinks to comfort him, and extra blankets on top while watching TV or retiring for bed.  Tired easily; would drift off to sleep sitting in chair about 10 or 11 AM; trouble focusing on reading or doing computer games. Took 3 and 4 hours naps in the afternoon but still felt like going to bed earlier than normal.  Day 7 or 8 felt significantly nauseous and queeezy on and off for three days, and didnt eat very much. Sudden headache in upper forehead area lasted about 3 hours on two consecutive days. Constipated days 8-14 so took a stool softener days 12 and 13 and ate more fruit.  Joints hurt, especially the right hip, to the point of not being able to dress himself days 6-13; could not do normal activities (stopped his daily exercise and walks, avoided getting up off couch or chair and asked me to bring things to him, used a cane when walking inside the house due to balance issues that got worse.  Tylenol and Tylenol PM were taken to manage pain and for sleep. Took additional vitamin C and ate mandarin oranges for healing.
Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Severe, Additional Details: Patient came to our pharmacy to pick up prescriptions for Diclofenac 50 mg and Norco 5/325, and informed me that ever since he received his Covid vaccine, his right shoulder has been in pain to the point that he could no longer sleep at night. I have called Store 4742 and informed the pharmacist on duty about this report from the patient the same afternoon.
Patient experienced redness of eyes, swelling of the throat, numbness and tingling of the fingers. Patient took 2 tables of diphenhydramine 25mg (50mg total) and is Feeling better. Patient denies having a rash.
No adverse event; Moderna first dose was administered on 13-May-2021 and second dose was administered on 27-Oct-2021; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna first dose was administered on 13-May-2021 and second dose was administered on 27-Oct-2021) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L21A, 071F211 and 0018221A) for COVID-19 prophylaxis.     Concurrent medical conditions included Atrial fibrillation and Arthritis.   On 13-May-2021 at 4:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021 at 5:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2022 at 5:00 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Oct-2021 at 5:00 PM, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna first dose was administered on 13-May-2021 and second dose was administered on 27-Oct-2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Moderna first dose was administered on 13-May-2021 and second dose was administered on 27-Oct-2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            The patient previously received a COVID-19 Vaccine. Patient received a fourth dose of moderna bivalent vaccine (Batch number: Unknown) in the right arm on 27-Sep-2022 at 12:30 PM. Concomitant medications details were not reported by the reporter. Device date was reported as 24-Nov-2022. Treatment details were not reported by the reporter.
My period is at least 6 days late, and i am never late and have not been sexually active for years, and am not on any birth control.  I?m mad that i?m hearing a lot of anecdotal evidence of side effects of the covid vaccine on menstrual cycles, but there is no clinical research into this or warnings about it
Child fainted immediately after injection. States this has happened before with injections. Epidode lasted 30 seconds. School nurse came and took her to the health office via wheelchair.
no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 23-MAR-2023, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This one of several reports received from the same reporter. ; Sender's Comments:  US-009507513-2304USA002221:
My temp is normally low.. between 96.7 and 97.6 (temp takin at work every day) We?d 5/26/21 Shot at 9:15am Fatugue & diarrhea started around 4pm Headache and hot cold flashes  begins around 7pm Vomiting with major chills and fever of 100.01 begins around 11pm Thurs 5/26/21 Vomiting continues til 7am Headache continues as well Temp down to 99.4 around 4pm Finally ate soup Headache continues throughout Thursday night Friday 5/28/21 Headache and body really really tired
IMMEDIATELY AFTER INJECTION PT C/O DIZZINESS AND SOB, ATTEMPTED TO ASSIT PT OUT OF CAR, PT STATED, "I CAN HARDLY WALK", PTS VEHICLE DRIVEN OUT OF VACCINATION TENT VIA GUARD. PT ASSISTED BACK TO CAR, PT CONTINUE TO C/O DIZZINESS AND SOB, BP-127/86, P-74, 02-100%, BLOOD GLUCOSE-83 MG/DL. 12:10P PT TRANSPORTED VIA AMR TO LOCAL ER.
pt recvd vax on 9DEC92 & immed following vax pt exp severe pain @ the inject site & passed out; No further details were provided;
patient received PENTACEL at 4 months, at 6 months and at 9 months with no reported adverse event; Initial information received  on 11-Apr-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 11 months old female patient and it was reported that patient received diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (vero)] at 4 months, 6 months and at 9 months with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitants and family history were not provided.   On 17-Jan-2023, the patient received 0.5 mL of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine Suspension for injection (batch/lot number: UJ754AB and expiry date: 26-Sep-2023; strength: standard) via intramuscular route in the left thigh for immunization. On 17-Oct-2022, she also received a dose of the same vaccine. On 29-Aug-2022 she also received a dose of the same vaccine (Product administered to patient of inappropriate age) (latency: same day).  It was reported that patient was administered 4 DTAP components by the age of 9 months. Caller confirmed that they have a patient who received DAPTACEL at 2 months, PENTACEL at 4 months, 6 months, and 9 months.  Action taken: Not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
17 year-old got vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old got vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old got vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 year-old got vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no concomitant medications are provided. treatment to the events not reported.
Injection site soreness, redness, swelling, and itch onset day after injection. Improving with cold compress, Tylenol, and Allegra starting day 3 after injection.
This spontaneous report as received from a pharmacy technician refers to an unspecified number of patients of unknown age and gender. The patients' pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (lot # L033707 with expiry date 18-MAY-2017; dose and route were not reported). No adverse effects were reported. This one of several reports received from the same reporter. Additional information has been requested.
30 minutes after receiving dose #2 moderna vaccine, pt experienced a headache. the headache has now persisted for 3 weeks and has not resolved. it varies from 3/10 pain to 7/10 pain. Acetaminophen, ibuprofen and excedrin have not relieved it. she has no other neurologic symptoms. She did not experience any other side effects from the vaccine other than headache. There was no other event that seems to be related to the headache.
1st dose from a different facility on 21Apr2021 and she is experiencing fever for the past 4 days.; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported for herself.   A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH covid-19 mRna vaccine, solution for injection), dose 1 via an unspecified route of administration on 21Apr2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that the patient received first dose from a different facility on 21Apr2021 and she experienced fever for the past 4 days on unknown date in Apr2021. Her 17 years old son was to receive the 2nd dose of vaccine tomorrow on 05May2021. She asked for the phone number of the facility because she misplaced the calling card for it. She doesn't remember when her son received the 1st dose (might missed second dose). At the time of this report, the outcome of event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Bump under right armpit felt/noticed on 01/16/2021.  It has almost disappeared. My psoriasis on arms/legs apparently temporarily cleared up.  It apparently may unfortunately be returning. My white blood cell count had apparently gotten back to normal levels after the 1st vaccine injection on 01/16/2021.
This patients accidently got two Moderna Bivalent Boosters within 3 months, one on 10/28/2022 and another one on 01/19/2023. Pt was notified right away.  Pt was contacted a few hours later same day and on 01/20/23 see how she was doing. Pt states she feels well except some pain at injection site. Pt was advised to seek medical care if she develops other vaccine side effects. Pt understood verbally.  Pt's PCP notified.
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: arm very swollen and has a hard lump after two weeks
Pt developed several vesicles and erythematous patches on left high about 1 week after vaccination. Distribution was L2 Dermatome, not crossing midline. General vaccinia vs herpes zoster. Diagnosis could not be confirmed with available resources. Treatment with acyclovir.
Facial nerve pain on right side of face from head to mouth.  this happened in the same area as an injury in 2018. The pain also came on 6 weeks after my first vaccine last Spring.  the pain lasted over 4 months in the previous vaccine series but I thought it was coincidental until it started happening again after this vaccine. I am experiencing nerve pain to the touch, hot/cold and even when the wind hits my face!
After shot, he said he felt his brain tearing or ripping apart and developed headache. Kept wetting head with water. Lost short-term memory. Unable to study, lost binocular vision to read or write.  Irritable Bowel Syndrome, Leaky gut, developed multiple Food allergies, Kidney failure, liver toxicity, spleen enlarged, became paralyzed - widespread from nose (mouth breather), Bell's palsy, to loss of urinary and bowel control, walked with a stroke shuffle at 16 years old, hypersensitive to sound, chronic insomnia, high cortisol during day and night. Lost weight, stopped growing, almost died in 2010 due to inability to swallow whole food. Lost all speech for 3 years.
Bilateral arm pain, low grade fever, fatigue, weakness, headaches, feeling of brain floating in fluid.
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Abdominal Pain-Medium, Systemic: Body Aches Generalized-Medium, Systemic: Chills-Severe, Systemic: Diarrhea-Medium, Systemic: Dizziness / Lightheadness-Medium, Systemic: Flushed / Sweating-Severe, Systemic: Hyperventilation-Mild, Systemic: Nausea-Severe, Systemic: Shakiness-Medium, Systemic: Vomiting-Medium, Additional Details: Within 5 minutes of administration patient experienced sweating, claminess, nausea, stomach upset, felling faint, slight dizziness, minor trouble breathing. After around 5 more minutes, patient vomitied. EMS was called and patient left pharmacy with EMS within 20 minutes of administration of vaccine.
Sore arm after the booster dose/minor soreness in her injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm after the booster dose/minor soreness in her injection site arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore arm after the booster dose/minor soreness in her injection site arm). At the time of the report, VACCINATION SITE PAIN (Sore arm after the booster dose/minor soreness in her injection site arm) outcome was unknown.            No concomitant medications were provided. Patient did not report any other adverse reactions. No treatment medications were provided.   Reporter did not allow further contact
swelling at the injection site; inflammation at the injection site; Initial information received on 05-Jun-2019 regarding an unsolicited valid non-serious case received from an other health care professional.  This case is linked to cases 2019SA157325, 2019SA157348 and 2019SA157350 (same reporter).  This case involves a male patient of unknown age who experienced swelling and inflammation at the injection site, while he received vaccine DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. No other vaccines were administered by patient on that day.  On 23-May-2019, the patient received a second dose of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot C5609AA and Exp. Date 04-Apr-2021) via intramuscular route in the right deltoid.  On an unknown date, the patient developed swelling at the injection site (vaccination site swelling) and inflammation at the injection site (vaccination site inflammation) following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE.  Details of lab data not reported.  Final diagnosis was inflammation and swelling at the injection site.   It was not reported if the patient received any corrective treatment.  The outcome of events not reported.  List of documents held by sender: none.
The day after the vaccine, I suffered a bad headache, chills, fever, dizziness, and general symptoms that felt similar to those I felt when diagnosed with COVID19 in 2020. The majority of the symptoms subsided the following day and the pressure of the headache subsided within 48 hours of first symptoms.
At 6:20am the following day almost 24 hours later, I woke up and started my day after a few minutes I felt numb and lost conscience for a few seconds. Then I was disoriented  and my husband took me back to bed where I slept for a few hours. And battled a fever for the rest of the day. Fever ranged between 100-101 for most of the day.
Hives - red and itchy on both arms, stomach and lower back - just a few bumps on each area.
periorbital swelling, upper/lower lip swelling Narrative: Developed facial swelling -periorbital 7 days after, upper/lower lips 14 days after- a/w other symptoms. Has prior h/o skin sensitivities and associated eczema flares, swelling/pruritus/skin flaking to areas where irritant was applied. Tried new facial cream 3x wks prior to initial vaccination. Began to have skin issues including itchy eye and discontinued the product's use after 4 consecutive days of use. Issues persisted during/after vaccination. Experienced an eczema flare over typical antecubital area and had continued/increased itchiness over b/l periorbital area, which she was constantly rubbing to try to alleviate itching. Then developed periorbital edema and noticed that her lips were itchy around the same time period. She scratched/rubbed her lips. The periorbital edema resolved slowly. Went to see her PCP about 2 weeks after vaccination. PCP noted upper and lower lip swelling (still itchy) and advised topical desonide. No other s/sx of angioedema. All swelling resolved during the week afterwards. No other adverse effects reported. Did feel less comfortable wearing mask for entire 10 hour shift in the afternoon for ~week after vaccination. Denied SOB, wheezing, stridor, increased work of breathing, fever, or chills.